Literature DB >> 15031171

An atypical phenotype of macular and peripapillary retinal atrophy caused by a mutation in the RP2 gene.

S S Dandekar1, N D Ebenezer, C Grayson, J P Chapple, C A Egan, G E Holder, S A Jenkins, F W Fitzke, M E Cheetham, A R Webster, A J Hardcastle.   

Abstract

AIMS: To determine the molecular basis and describe the phenotype of an atypical retinal dystrophy in a family presenting with bilateral, progressive central visual loss.
METHODS: Family members were examined. Investigations included Goldman perimetry, electrophysiology, and autofluorescence imaging. Candidate gene screening was performed using SSCP and sequence analysis. The proband's lymphoblastoid cells were examined for protein expression.
RESULTS: Fundal examination of the proband, his mother, and brother revealed peripapillary and macular atrophy. Autosomal dominant retinal dystrophy was suspected, but less severe disease in the mother led to screening for mutations in X linked genes. A 4 bp microdeletion in exon 3 of the RP2 gene, segregating with disease, was identified. No RP2 protein expression was detected.
CONCLUSION: The distinct phenotype in this family, caused by this frameshifting mutation in RP2, broadens the phenotypic spectrum of X linked retinitis pigmentosa. The absence of RP2 protein suggests that loss of protein function and not novel gain of function could account for the atypical phenotype. A definitive diagnosis of X linked retinitis pigmentosa permits appropriate genetic counselling with important implications for other family members. Clinicians should have a low threshold for screening RP2 in families with retinal dystrophy, including posterior retinal disease, not immediately suggestive of X linked inheritance.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15031171      PMCID: PMC1772091          DOI: 10.1136/bjo.2003.027979

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  35 in total

1.  X-linked retinitis pigmentosa.

Authors:  A C Bird
Journal:  Br J Ophthalmol       Date:  1975-04       Impact factor: 4.638

2.  Multipoint linkage analysis and heterogeneity testing in 20 X-linked retinitis pigmentosa families.

Authors:  M A Musarella; L Anson-Cartwright; S M Leal; L D Gilbert; R G Worton; G A Fishman; J Ott
Journal:  Genomics       Date:  1990-10       Impact factor: 5.736

3.  X-linked recessive fundus dystrophies and their carrier states.

Authors:  A C Bird; R K Blach
Journal:  Trans Ophthalmol Soc U K       Date:  1970

4.  Retinitis pigmentosa. Visual loss.

Authors:  G A Fishman
Journal:  Arch Ophthalmol       Date:  1978-07

5.  Delineation of the plasma membrane targeting domain of the X-linked retinitis pigmentosa protein RP2.

Authors:  J Paul Chapple; Alison J Hardcastle; Celene Grayson; Keith R Willison; Michael E Cheetham
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-06       Impact factor: 4.799

Review 6.  Mutations of RPGR in X-linked retinitis pigmentosa (RP3).

Authors:  Raf Vervoort; Alan F Wright
Journal:  Hum Mutat       Date:  2002-05       Impact factor: 4.878

7.  X-linked recessive atrophic macular degeneration from RPGR mutation.

Authors:  Radha Ayyagari; F Yesim Demirci; Jiafan Liu; Eve L Bingham; Heather Stringham; Laura E Kakuk; Michael Boehnke; Michael B Gorin; Julia E Richards; Paul A Sieving
Journal:  Genomics       Date:  2002-08       Impact factor: 5.736

8.  Close genetic linkage between X-linked retinitis pigmentosa and a restriction fragment length polymorphism identified by recombinant DNA probe L1.28.

Authors:  S S Bhattacharya; A F Wright; J F Clayton; W H Price; C I Phillips; C M McKeown; M Jay; A C Bird; P L Pearson; E M Southern
Journal:  Nature       Date:  1984 May 17-23       Impact factor: 49.962

9.  Electroretinographic testing as an aid in detection of carriers of X-chromosome-linked retinitis pigmentosa.

Authors:  E L Berson; J B Rosen; E A Simonoff
Journal:  Am J Ophthalmol       Date:  1979-04       Impact factor: 5.258

10.  X-linked recessive retinitis pigmentosa. Clinical characteristics of carriers.

Authors:  G A Fishman; A B Weinberg; T T McMahon
Journal:  Arch Ophthalmol       Date:  1986-09
View more
  9 in total

1.  ABCA4-associated retinal degenerations spare structure and function of the human parapapillary retina.

Authors:  Artur V Cideciyan; Malgorzata Swider; Tomas S Aleman; Alexander Sumaroka; Sharon B Schwartz; Marisa I Roman; Ann H Milam; Jean Bennett; Edwin M Stone; Samuel G Jacobson
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-12       Impact factor: 4.799

2.  RP2 phenotype and pathogenetic correlations in X-linked retinitis pigmentosa.

Authors:  Thiran Jayasundera; Kari E H Branham; Mohammad Othman; William R Rhoades; Athanasios J Karoukis; Hemant Khanna; Anand Swaroop; John R Heckenlively
Journal:  Arch Ophthalmol       Date:  2010-07

3.  Deep intronic mutation in OFD1, identified by targeted genomic next-generation sequencing, causes a severe form of X-linked retinitis pigmentosa (RP23).

Authors:  Tom R Webb; David A Parfitt; Jessica C Gardner; Ariadna Martinez; Dalila Bevilacqua; Alice E Davidson; Ilaria Zito; Dawn L Thiselton; Jacob H C Ressa; Marina Apergi; Nele Schwarz; Naheed Kanuga; Michel Michaelides; Michael E Cheetham; Michael B Gorin; Alison J Hardcastle
Journal:  Hum Mol Genet       Date:  2012-05-22       Impact factor: 6.150

4.  Intellectual disability associated with retinal dystrophy in the Xp11.3 deletion syndrome: ZNF674 on trial. Guilty or innocent?

Authors:  Nathalie Delphin; Sylvain Hanein; Lucas Fares Taie; Xavier Zanlonghi; Dominique Bonneau; Jean-Paul Moisan; Christine Boyle; Patrick Nitschke; Solenn Pruvost; Jean-Paul Bonnefont; Arnold Munnich; Olivier Roche; Josseline Kaplan; Jean-Michel Rozet
Journal:  Eur J Hum Genet       Date:  2011-11-30       Impact factor: 4.246

5.  Novel non-sense mutation in RP2 (c.843_844insT/p.Arg282fs) is associated with a severe phenotype of retinitis pigmentosa without evidence of primary retinal pigment epithelium involvement.

Authors:  Faye Horner; James Wawrzynski; Robert E MacLaren
Journal:  BMJ Case Rep       Date:  2019-05-10

6.  Mistrafficking of prenylated proteins causes retinitis pigmentosa 2.

Authors:  Houbin Zhang; Christin Hanke-Gogokhia; Li Jiang; Xiaobo Li; Pu Wang; Cecilia D Gerstner; Jeanne M Frederick; Zhenglin Yang; Wolfgang Baehr
Journal:  FASEB J       Date:  2014-11-24       Impact factor: 5.191

Review 7.  Using induced pluripotent stem cells to understand retinal ciliopathy disease mechanisms and develop therapies.

Authors:  David A Parfitt; Amelia Lane; Conor Ramsden; Katarina Jovanovic; Peter J Coffey; Alison J Hardcastle; Michael E Cheetham
Journal:  Biochem Soc Trans       Date:  2016-10-15       Impact factor: 5.407

8.  Pathogenic mutations in retinitis pigmentosa 2 predominantly result in loss of RP2 protein stability in humans and zebrafish.

Authors:  Fei Liu; Yayun Qin; Shanshan Yu; Dinesh C Soares; Lifang Yang; Jun Weng; Chang Li; Meng Gao; Zhaojing Lu; Xuebin Hu; Xiliang Liu; Tao Jiang; Jing Yu Liu; Xinhua Shu; Zhaohui Tang; Mugen Liu
Journal:  J Biol Chem       Date:  2017-02-16       Impact factor: 5.157

9.  Translational read-through of the RP2 Arg120stop mutation in patient iPSC-derived retinal pigment epithelium cells.

Authors:  Nele Schwarz; Amanda-Jayne Carr; Amelia Lane; Fabian Moeller; Li Li Chen; Mònica Aguilà; Britta Nommiste; Manickam N Muthiah; Naheed Kanuga; Uwe Wolfrum; Kerstin Nagel-Wolfrum; Lyndon da Cruz; Peter J Coffey; Michael E Cheetham; Alison J Hardcastle
Journal:  Hum Mol Genet       Date:  2014-10-06       Impact factor: 6.150

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.